Stem cells for the treatment of myelin loss

Treatment of myelin loss is particularly suited to therapeutic strategies based on cell replacement. Demyelination represents a defined and functionally debilitating deficit, and remyelination can be accomplished by supplying regions of demyelination with myelinogenic cell populations. Clinical interest in stem cells as a source of myelinogenic cells arises from their ability to provide an apparently unlimited cell supply for transplantation, and from recent demonstrations that they can be directed to myelinogenic phenotypes with high purity. Here, I present the emerging perspective that stem-cell-mediated remyelination of the adult CNS is a viable therapeutic strategy, and discuss the challenges to remyelination posed by the environment of acute and chronic injuries.

[1]  M. Richards,et al.  Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells , 2002, Nature Biotechnology.

[2]  T. Ben-Hur,et al.  Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis , 2003, Glia.

[3]  H. Okano,et al.  Transplantation of human neural stem cells for spinal cord injury in primates , 2005, Journal of neuroscience research.

[4]  M. Schumacher,et al.  Steroids and the reversal of age-associated changes in myelination and remyelination , 2003, Progress in Neurobiology.

[5]  H. Keirstead,et al.  Stem cell transplantation into the central nervous system and the control of differentiation , 2001, Journal of neuroscience research.

[6]  T. Berney,et al.  Transplantation of Discordant Xenogeneic Islets Using Repeated Therapy with Anti-CD154 , 2005, Transplantation.

[7]  R. Franklin,et al.  Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. , 2003, Brain : a journal of neurology.

[8]  A. Benraiss,et al.  Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain , 2002, Journal of neuroscience research.

[9]  I. Duncan,et al.  Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Costantino-Ceccarini,et al.  Krabbe disease: genetic aspects and progress toward therapy. , 2000, Molecular genetics and metabolism.

[11]  Robert A Pearce,et al.  Specification of motoneurons from human embryonic stem cells , 2005, Nature Biotechnology.

[12]  Trevor Douglas,et al.  MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain , 2003, Magnetic resonance in medicine.

[13]  Benjamin E. Reubinoff,et al.  Neural progenitors from human embryonic stem cells , 2001, Nature Biotechnology.

[14]  Nenad Blau,et al.  The neurochemistry of phenylketonuria , 2000, European Journal of Pediatrics.

[15]  K. Latham.  Early and delayed aspects of nuclear reprogramming during cloning , 2005, Biology of the cell.

[16]  Z. Lengyel,et al.  Autopsy verifies demyelination and lack of vascular damage in partially reversible radiation myelopathy , 2003, Spinal Cord.

[17]  F. Cotton,et al.  Diffusion-weighted magnetic resonance imaging in Marchiafava–Bignami disease: follow-up studies , 2005, Neuroradiology.

[18]  Oliver Brüstle,et al.  Retinoic acid induction of ES-cell-derived neurons: the radial glia connection , 2005, Trends in Neurosciences.

[19]  S. Roh,et al.  Establishment and Maintenance of Human Embryonic Stem Cell Lines on Human Feeder Cells Derived from Uterine Endometrium under Serum-Free Condition1 , 2005, Biology of reproduction.

[20]  W. Blakemore,et al.  Inflammation stimulates remyelination in areas of chronic demyelination. , 2005, Brain : a journal of neurology.

[21]  J. Levine,et al.  Response of the oligodendrocyte progenitor cell population (defined by NG2 labelling) to demyelination of the adult spinal cord , 1998, Glia.

[22]  B. Banwell,et al.  Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease , 2005, Annals of neurology.

[23]  A. Crang,et al.  The demonstration by transplantation of the very restricted remyelinating potential of post-mitotic oligodendrocytes , 1998, Journal of neurocytology.

[24]  H. Keirstead,et al.  Spinal cord injury is accompanied by chronic progressive demyelination , 2005, The Journal of comparative neurology.

[25]  J. Kocsis,et al.  Transplantation of Cryopreserved Adult Human Schwann Cells Enhances Axonal Conduction in Demyelinated Spinal Cord , 2001, The Journal of Neuroscience.

[26]  T. Holekamp,et al.  Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Talwar,et al.  CAMFAK syndrome: a demyelinating inherited disease similar to Cockayne syndrome. , 1989, American journal of medical genetics.

[28]  R. Galli,et al.  Neural Stem Cells: An Overview , 2003, Circulation research.

[29]  M. Carpenter,et al.  Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation , 2005, Glia.

[30]  T. Ben-Hur,et al.  Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis , 2003, Molecular and Cellular Neuroscience.

[31]  H. McFarland,et al.  Multiple sclerosis: Re‐expression of a developmental gene in chronic lesions correlates with remyelination , 1997, Annals of neurology.

[32]  R. Rudick,et al.  Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. , 2002, The New England journal of medicine.

[33]  P. Gutin,et al.  Parthenogenetic Stem Cells in Nonhuman Primates , 2002, Science.

[34]  J. Powers.  Demyelination in peroxisomal diseases , 2005, Journal of the Neurological Sciences.

[35]  A. Federico,et al.  Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. , 2001, Brain : a journal of neurology.

[36]  E. Kolodny.  Dysmyelinating and demyelinating conditions in infancy. , 1993, Current opinion in neurology and neurosurgery.

[37]  M. Noble,et al.  Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O- 2Aperinatal progenitor cells , 1992, The Journal of cell biology.

[38]  J. Lafuente,et al.  Traumatic brain injuries: structural changes , 1991, Journal of the Neurological Sciences.

[39]  H. Keirstead,et al.  Identification of Post‐mitotic Oligodendrocytes Incapable of Remyelination within the Demyelinated Adult Spinal Cord , 1997, Journal of neuropathology and experimental neurology.

[40]  R. Martin.  Central pontine and extrapontine myelinolysis: the osmotic demyelination syndromes , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  H. Keirstead,et al.  Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis , 2004, Experimental Neurology.

[42]  R. Franklin,et al.  Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin‐induced CNS demyelination , 1999, Glia.

[43]  T. Shimazaki,et al.  Isolation and transplantation of dopaminergic neurons generated from mouse embryonic stem cells , 2004, Neuroscience Letters.

[44]  E. Jauniaux,et al.  Human Neural Precursor Cells Express Low Levels of Telomerase in Vitro and Show Diminishing Cell Proliferation with Extensive Axonal Outgrowth following Transplantation , 2000, Experimental Neurology.

[45]  S. Love.  Establishing preconditions for Baló's concentric sclerosis. , 2005, Brain : a journal of neurology.

[46]  W. Blakemore,et al.  Use of a rat Y chromosome probe to determine the long-term survival of glial cells transplanted into areas of CNS demyelination , 1997, Journal of neurocytology.

[47]  E. Richfield,et al.  EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy , 2005, Nature Medicine.

[48]  A. Crang,et al.  Behavioural consequences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord , 1999, The European journal of neuroscience.

[49]  Oswald Steward,et al.  Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury , 2005, The Journal of Neuroscience.

[50]  H. Blau,et al.  Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Hipp,et al.  Nonhuman primate parthenogenetic stem cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[52]  P. Rathjen,et al.  Differentiation of embryonic stem cells to a neural fate: A route to re‐building the nervous system? , 2004, Journal of neuroscience research.

[53]  J. Goldman,et al.  Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. , 2004, The American journal of pathology.

[54]  M. Rao,et al.  Enrichment of Neurons and Neural Precursors from Human Embryonic Stem Cells , 2001, Experimental Neurology.

[55]  H. Okano,et al.  Transplantation of in vitro‐expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats , 2002, Journal of neuroscience research.

[56]  K. Levin.  Variants and Mimics of Guillain Barré Syndrome , 2004, The neurologist.

[57]  Jim Mintz,et al.  Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease. , 2005, Journal of Alzheimer's disease : JAD.

[58]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[59]  M. Shy,et al.  The molecular pathogenesis of Pelizaeus-Merzbacher disease. , 1999, Archives of neurology.

[60]  G. Mancardi,et al.  Marburg type and Balò’s concentric sclerosis: rare and acute variants of multiple sclerosis , 2004, Neurological Sciences.

[61]  U. Mödder,et al.  Diffusion-weighted MR imaging in the brain in children: findings in the normal brain and in the brain with white matter diseases. , 2002, Radiology.

[62]  K. Houkin,et al.  Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord , 2003, Glia.

[63]  E. Cho,et al.  Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions , 1993 .

[64]  P. Kang,et al.  Multifocal slowing of nerve conduction in metachromatic leukodystrophy , 2004, Muscle & nerve.

[65]  C. Brosnan,et al.  Multiple sclerosis: Re-expression of a developmental pathway that restricts oligodendrocyte maturation , 2002, Nature Medicine.

[66]  P. Aubourg,et al.  The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder , 1999, Trends in Neurosciences.

[67]  D. Gottlieb,et al.  Synapse formation and establishment of neuronal polarity by P19 embryonic carcinoma cells and embryonic stem cells , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[68]  R. W. Pratt,et al.  Medication and toxin-induced peripheral neuropathy. , 2005, Seminars in neurology.

[69]  R. Reynolds,et al.  Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? , 2002, Brain : a journal of neurology.

[70]  H. Lassmann.  Classification of demyelinating diseases at the interface between etiology and pathogenesis , 2001, Current opinion in neurology.

[71]  Scott Pollack,et al.  Growth factors regulate the survival and fate of cells derived from human neurospheres , 2001, Nature Biotechnology.

[72]  K. Toyka,et al.  Inherited demyelinating neuropathies: from gene to disease. , 1998, Current opinion in neurology.

[73]  S. Waxman,et al.  Chapter 29 Enhancement of action potential conduction following demyelination: experimental approaches to restoration of function in multiple sclerosis and spinal cord injury , 1994 .

[74]  P. Hof,et al.  Cortical Microinfarcts and Demyelination Significantly Affect Cognition in Brain Aging , 2004, Stroke.

[75]  A. Pérez-Bouza,et al.  Generation of purified oligodendrocyte progenitors from embryonic stem cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  Xavier Navarro,et al.  Influence of aging on peripheral nerve function and regeneration. , 2000 .

[77]  N. Scolding.  Devic's disease and autoantibodies , 2005, The Lancet Neurology.

[78]  Bruce D. Trapp,et al.  Axonal pathology in myelin disorders , 1999, Journal of neurocytology.

[79]  B. Crain,et al.  Transplanted bone marrow generates new neurons in human brains , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[80]  S. Waxman,et al.  Transplanted Olfactory Ensheathing Cells Remyelinate and Enhance Axonal Conduction in the Demyelinated Dorsal Columns of the Rat Spinal Cord , 1998, The Journal of Neuroscience.

[81]  S. Dunnett,et al.  Long-Term Survival of Human Central Nervous System Progenitor Cells Transplanted into a Rat Model of Parkinson's Disease , 1997, Experimental Neurology.

[82]  R. McKay,et al.  Embryonic stem cell-derived glial precursors: a source of myelinating transplants. , 1999, Science.

[83]  J. Kocsis,et al.  Remyelination of the Rat Spinal Cord by Transplantation of Identified Bone Marrow Stromal Cells , 2002, The Journal of Neuroscience.

[84]  Angelo L. Vescovi,et al.  Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis , 2003, Nature.

[85]  D. Steindler,et al.  Bone marrow transdifferentiation in brain after transplantation: a retrospective study , 2004, The Lancet.

[86]  Martin Raff,et al.  Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells , 2002, Journal of Cell Science.

[87]  A. Zimmerman,et al.  Ultrastructure and electrodiagnosis of peripheral neuropathy in Cockayne's syndrome , 1983, Neurology.

[88]  G. Wolswijk.  Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. , 2000, Brain : a journal of neurology.